FJX1 and nasopharyngeal carcinoma: Notably, the human FJX1 chromosomal region, is reported to be amplified and overexpressed in oral cancer tissues and cell lines [34–35], suggesting that the protein may be a viable tumor antigen for head and neck cancers including oral cancer and NPC.